Canada Life’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
127,700
+5,677
| +5% | +$123K | ﹤0.01% | 1053 |
|
|
2025
Q1 | $2.96M | Sell |
122,023
-11,184
| -8% | -$271K | 0.01% | 1030 |
|
|
2024
Q4 | $2.78M | Sell |
133,207
-4,007
| -3% | -$83.6K | ﹤0.01% | 1117 |
|
|
2024
Q3 | $2.73M | Sell |
137,214
-3,725
| -3% | -$74.1K | ﹤0.01% | 1165 |
|
|
2024
Q2 | $2.18M | Sell |
140,939
-6,306
| -4% | -$97.6K | ﹤0.01% | 1250 |
|
|
2024
Q1 | $2.35M | Buy |
147,245
+16,599
| +13% | +$264K | ﹤0.01% | 1166 |
|
|
2023
Q4 | $2.19M | Sell |
130,646
-8,488
| -6% | -$142K | ﹤0.01% | 1208 |
|
|
2023
Q3 | $1.62M | Buy |
139,134
+8,348
| +6% | +$97.4K | ﹤0.01% | 1312 |
|
|
2023
Q2 | $1.76M | Sell |
130,786
-4,327
| -3% | -$58.3K | ﹤0.01% | 1265 |
|
|
2023
Q1 | $2.24M | Sell |
135,113
-9,531
| -7% | -$158K | 0.01% | 1173 |
|
|
2022
Q4 | $2.7M | Buy |
144,644
+21,671
| +18% | +$404K | 0.01% | 1071 |
|
|
2022
Q3 | $1.58M | Buy |
122,973
+117,547
| +2,166% | +$1.51M | ﹤0.01% | 1289 |
|
|
2022
Q2 | $38K | Hold |
5,426
| – | – | ﹤0.01% | 2109 |
|
|
2022
Q1 | $48K | Hold |
5,426
| – | – | ﹤0.01% | 2168 |
|
|
2021
Q4 | $37K | Hold |
5,426
| – | – | ﹤0.01% | 2252 |
|
|
2021
Q3 | $29K | Hold |
5,426
| – | – | ﹤0.01% | 2363 |
|
|
2021
Q2 | $31K | Hold |
5,426
| – | – | ﹤0.01% | 2394 |
|
|
2021
Q1 | $25K | Hold |
5,426
| – | – | ﹤0.01% | 2473 |
|
|
2020
Q4 | $18K | Hold |
5,426
| – | – | ﹤0.01% | 2556 |
|
|
2020
Q3 | $16K | Hold |
5,426
| – | – | ﹤0.01% | 2478 |
|
|
2020
Q2 | $25K | Hold |
5,426
| – | – | ﹤0.01% | 2438 |
|
|
2020
Q1 | $21K | Hold |
5,426
| – | – | ﹤0.01% | 2357 |
|
|
2019
Q4 | $20K | Buy |
+5,426
| New | +$20K | ﹤0.01% | 2494 |
|
|
2019
Q3 | – | Sell |
-10,227
| Closed | -$39K | – | 1376 |
|
|
2019
Q2 | $39K | Buy |
+10,227
| New | +$39K | ﹤0.01% | 2500 |
|